Trastuzumab biosimilar - Biocon
At a glance
- Drug Originator Biocon; Mylan
- Drug Licenced by Abdi Ibrahim Remede Pharma; Libbs Farmaceutica; Sandoz
- Drug Class Antineoplastics; Immunotherapies; Monoclonal antibodies
- Mechanism of Action ERBB 2 receptor antagonists
- USA Patent Applicants MYLAN GMBH
- USA Patents 1
- BLAs 1
- International Patents 4

Disclaimer